El 4 de octubre de 2019 el Dr. Jose Luis Mostaza Fernández (Jefe Servicio MI) comentó los siguientes artículos del LID:

• Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with hematological malignancies: a phase 3, randomized, clinical trial and post-hoc efficacy analysis.
• Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two arm, randomized, double blind, phase 3 trial.
• Varicella zoster virus vaccine in patients with hematological malignancies.
• Herpes zoster in people who are immunocompromised: what are the options for prevention?
• Novel lipoarabinomannan point of care tuberculosis test for people with HIV: a diagnostic accuracy study.
• Global burden of latent multidrug resistant tuberculosis: trends and estimates based on mathematical modelling.
• Chlorhexidine for meatal cleaning in reducing catheter associated urinary tract infections: a multicentre stepped wedge randomised controlled trial.

La presentación se puede ver en este enlace